Comparative Pharmacology
Head-to-head clinical analysis: INULIN AND SODIUM CHLORIDE versus MAGNESIUM SULFATE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INULIN AND SODIUM CHLORIDE versus MAGNESIUM SULFATE IN PLASTIC CONTAINER.
INULIN AND SODIUM CHLORIDE vs MAGNESIUM SULFATE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inulin is a polysaccharide that is not absorbed from the gastrointestinal tract and is used as a diagnostic agent to measure glomerular filtration rate (GFR) by renal clearance. Sodium chloride provides electrolyte supplementation.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Inulin: 5 g IV bolus followed by continuous infusion at 1.5 mL/min of a 10 g/L solution for GFR measurement. Sodium chloride: 0.9% solution as diluent.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
None Documented
None Documented
Normal renal function: 1.5 hours (range 1–2 h); decreases to 0.5 h with severe renal impairment; used to measure glomerular filtration rate (GFR)
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Renal: 100% as unchanged drug via glomerular filtration without tubular reabsorption or secretion; biliary/fecal: negligible (<1%)
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Category A/B
Category C
Electrolyte
Electrolyte